Admission haemoglobin and albumin as correlates of central nervous system inflammation in rhodesiense human African trypanosomiasis at Rumphi District Hospital, Malawi
Journal of Public Health in Africa·
- DOI
- 10.4102/jphia.v17i1.1775
- PMID
- —
- PMCID
- —
- OpenAlex
- W7204277548
- Study type
- Journal article
- Publisher
- AOSIS
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The findings suggest that readily accessible blood measures may help district hospitals recognize and monitor central nervous system involvement in Rhodesiense human African trypanosomiasis, potentially supporting triage decisions where cerebrospinal-fluid sampling is not routinely available.
Structured evidence summary
Research question
The study aimed to evaluate whether routine admission clinical and laboratory measures could serve as indicators of cerebrospinal-fluid inflammation in Rhodesiense human African trypanosomiasis, and to characterize changes in cerebrospinal-fluid white-cell counts during early hospital care.
Study design
This was a retrospective analysis of patients with parasitologically confirmed Rhodesiense human African trypanosomiasis seen at a single district hospital over a 12-year period. The study analyzed cerebrospinal-fluid white-cell counts at admission and Day 11 using mixed-effects negative binomial regression.
Population and setting
The study was conducted at Rumphi District Hospital in northern Malawi, a public secondary-level facility serving rural communities in the Vwaza Marsh focus. Eligible patients were aged 6 years or older with confirmed infection during 2012–2024.
Main findings
Cerebrospinal-fluid white-cell counts declined substantially during early care, being 75% lower at Day 11 compared to admission. Higher inflammatory burden was observed in Stage 2 compared to Stage 1 disease. Both higher haemoglobin and higher albumin levels were independently associated with lower expected cerebrospinal-fluid white-cell counts.
Public-health relevance
The findings suggest that readily accessible blood measures may help district hospitals recognize and monitor central nervous system involvement in Rhodesiense human African trypanosomiasis, potentially supporting triage decisions where cerebrospinal-fluid sampling is not routinely available.
Important limitations
This summary is limited to the supplied single-article abstract and metadata. The study's retrospective design, single-center setting, and modest sample size (43 patients) warrant caution in generalizing findings. The authors note that prospective diagnostic-accuracy validation would be needed before clinical implementation of these measures.
GIDS interpretation
This retrospective observational study from a defined rural focus of northern Malawi provides preliminary evidence linking routine blood measures to cerebrospinal-fluid inflammatory markers in Rhodesiense human African trypanosomiasis. The findings are descriptive and hypothesis-generating; they do not establish these measures as validated diagnostic or triage tools.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.